BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28751108)

  • 1. Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature.
    Meijer OLM; Te Brinke H; Ofman R; IJlst L; Wijburg FA; van Vlies N
    Mol Genet Metab; 2017 Sep; 122(1-2):100-106. PubMed ID: 28751108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Screen Fails to Identify Compounds That Enhance Residual Enzyme Activity of Mutant N-Acetyl-α-Glucosaminidase in Mucopolysaccharidosis Type IIIB.
    Meijer OLM; van den Biggelaar P; Ofman R; Wijburg FA; van Vlies N
    JIMD Rep; 2018; 39():97-106. PubMed ID: 28836185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB.
    Meijer OLM; Welling L; Valstar MJ; Hoefsloot LH; Brüggenwirth HT; van der Ploeg AT; Ruijter GJG; Wagemans T; Wijburg FA; van Vlies N
    J Inherit Metab Dis; 2016 May; 39(3):437-445. PubMed ID: 26907177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase.
    Weber B; Hopwood JJ; Yogalingam G
    Protein Expr Purif; 2001 Mar; 21(2):251-9. PubMed ID: 11237686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family.
    Li J; Xie H; Jiang Y
    BMC Med Genet; 2018 Apr; 19(1):51. PubMed ID: 29606097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.
    Villani GR; Follenzi A; Vanacore B; Di Domenico C; Naldini L; Di Natale P
    Biochem J; 2002 Jun; 364(Pt 3):747-53. PubMed ID: 12049639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
    Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH
    PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
    Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
    J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
    Aronovich EL; Johnston JM; Wang P; Giger U; Whitley CB
    Genomics; 2001 Jun; 74(3):299-305. PubMed ID: 11414757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector.
    Rouse CJ; Hawkins K; Kabbej N; Dalugdug J; Kunta A; Kim MJ; Someya S; Herbst Z; Gelb M; Dinelli I; Butterworth E; Falk DJ; Rosenkrantz E; Elmohd H; Khaledi H; Mowafy S; Ashby F; Heldermon CD
    Hum Mol Genet; 2023 Jan; 32(3):417-430. PubMed ID: 35997776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).
    Beesley CE; Young EP; Vellodi A; Winchester BG
    J Med Genet; 1998 Nov; 35(11):910-4. PubMed ID: 9832037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
    Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
    Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector.
    Di Natale P; Di Domenico C; Gargiulo N; Castaldo S; Gonzalez Y Reyero E; Mithbaokar P; De Felice M; Follenzi A; Naldini L; Villani GR
    Biochem J; 2005 Jun; 388(Pt 2):639-46. PubMed ID: 15649123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB).
    Champion KJ; Basehore MJ; Wood T; Destrée A; Vannuffel P; Maystadt I
    Mol Genet Metab; 2010 May; 100(1):51-6. PubMed ID: 20138557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis type IIIB: characterisation and expression of wild-type and mutant recombinant alpha-N-acetylglucosaminidase and relationship with sanfilippo phenotype in an attenuated patient.
    Yogalingam G; Weber B; Meehan J; Rogers J; Hopwood JJ
    Biochim Biophys Acta; 2000 Nov; 1502(3):415-25. PubMed ID: 11068184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAGLU mutations underlying Sanfilippo syndrome type B.
    Schmidtchen A; Greenberg D; Zhao HG; Li HH; Huang Y; Tieu P; Zhao HZ; Cheng S; Zhao Z; Whitley CB; Di Natale P; Neufeld EF
    Am J Hum Genet; 1998 Jan; 62(1):64-9. PubMed ID: 9443878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.